Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China flag China · Delayed Price · Currency is CNY
19.45
-0.15 (-0.77%)
Sep 16, 2026, 3:00 PM CST

SHA:600332 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
13,28914,94018,27321,30922,50022,377
Short-Term Investments
12,3738,8614,446729.162,117-
Trading Asset Securities
-4-456.87-
Cash & Short-Term Investments
25,66223,80522,71922,04224,67322,377
Cash Growth
22.96%4.78%3.07%-10.66%10.26%14.61%
Accounts Receivable
23,17320,94019,45619,59819,16817,211
Other Receivables
1,3321,186993.65882.35920.511,276
Receivables
24,50622,12620,44920,48020,08818,486
Inventory
12,09413,13812,81211,50710,67210,438
Other Current Assets
2,1192,4491,7821,9551,6311,510
Total Current Assets
64,38161,51857,76255,98457,06452,811
Property, Plant & Equipment
8,4968,3657,9397,5166,5705,684
Long-Term Investments
8,7708,79310,1469,4525,8972,891
Goodwill
919.94834.09830.85829.47829.47829.47
Other Intangible Assets
3,1593,1812,8292,8862,5852,582
Long-Term Deferred Tax Assets
1,3521,2861,2101,164865.34794.23
Long-Term Deferred Charges
160.09162.47558.49499.77407.47143.05
Other Long-Term Assets
584.23370.9407.77256.22446.54382.46
Total Assets
87,82284,51181,68478,58774,66566,118

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
16,93517,57116,32015,68614,96114,733
Accrued Expenses
3,5953,5693,6733,6513,4843,478
Short-Term Debt
12,8749,8609,1237,7999,1468,428
Current Portion of Long-Term Debt
1,2982,0271,33236.45498.5830.03
Current Portion of Leases
179.93185.2190.57213.38208.15215.77
Current Income Taxes Payable
156.3170.9118.4249.26237143.41
Current Unearned Revenue
1,2292,8335,0725,4305,6442,740
Other Current Liabilities
2,7122,9093,0883,1703,2162,485
Total Current Liabilities
38,97939,12538,91636,23537,39532,254
Long-Term Debt
5,0863,1742,8063,3241,639752.81
Long-Term Leases
404.53371.47445.72578.19545.84497.7
Long-Term Unearned Revenue
1,0781,0421,0021,001930.93826.86
Pension & Post-Retirement Benefits
0.280.290.30.290.320.3
Long-Term Deferred Tax Liabilities
599.48599.37625.56639.53394.59331.73
Other Long-Term Liabilities
189.54116.74119.31130.6121.45127.87
Total Liabilities
46,33744,42843,91441,90941,02734,791

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,6261,6261,6261,6261,6261,626
Additional Paid-In Capital
10,32410,32410,11410,10610,1069,957
Retained Earnings
27,22625,86124,17923,21220,34717,497
Comprehensive Income & Other
-42.91-22.6-13.84-24.34-12.9-17.48
Total Common Equity
39,13237,78835,90534,91932,06529,062
Minority Interest
2,3532,2951,8651,7591,5732,264
Shareholders' Equity
41,48540,08337,77036,67833,63831,327
Total Liabilities & Equity
87,82284,51181,68478,58774,66566,118

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
19,84215,61713,89711,95112,0389,924
Net Cash (Debt)
5,8208,1888,82310,09112,63512,453
Net Cash Growth
16.77%-7.20%-12.57%-20.14%1.47%24.99%
Net Cash Per Share
3.585.045.436.217.777.66
Filing Date Shares Outstanding
1,6261,6261,6261,6261,6261,626
Total Common Shares Outstanding
1,6261,6261,6261,6261,6261,626
Working Capital
25,40222,39418,84719,74819,66920,557
Book Value Per Share
24.0723.2422.0821.4819.7217.88
Tangible Book Value
35,05333,77332,24531,20328,65125,650
Tangible Book Value Per Share
21.5620.7719.8319.1917.6215.78
Buildings
6,5556,4645,2134,3283,6303,317
Machinery
5,6115,5215,1064,4164,0253,582
Construction In Progress
1,3741,1501,8462,4052,1081,564